We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03221842
Brief Title: Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

First Submitted : July 17, 2017
First Submitted that Met QC Criteria : July 17, 2017
First Posted : July 19, 2017

Results First Submitted : November 18, 2021
Results First Posted with QC Comments : December 17, 2021
Results First Submitted that Met QC Criteria : December 17, 2021
Results First Posted : January 18, 2022

Last Update Submitted that Met QC Criteria : July 25, 2022
Last Update Posted : July 29, 2022